Floating Button
Home Capital Broker's Calls

'Buy' InnoTek as it gains traction in EV, healthcare and consumer industries: UOB Kay Hian

Atiqah Mokhtar
Atiqah Mokhtar • 2 min read
'Buy' InnoTek as it gains traction in EV, healthcare and consumer industries: UOB Kay Hian
UOB Kay Hian believes InnoTek can achieve y-o-y earnings growth of 28% for FY21.
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

UOB Kay Hian analyst John Cheong is upbeat on InnoTek’s prospects coming off its 1HFY2021 ended June results.

He has maintained his “buy” call for the counter with an unchanged target price of $1.20.

Cheong notes that InnoTek’s 1HFY2021 earnings of $7.2 million were in line with his estimates, meeting 41% of his full-year forecast.

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2026 The Edge Publishing Pte Ltd. All rights reserved.